{"id":10251,"date":"2021-04-12T16:21:59","date_gmt":"2021-04-12T15:21:59","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=10251"},"modified":"2021-10-11T15:13:25","modified_gmt":"2021-10-11T14:13:25","slug":"live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/","title":{"rendered":"Live webinar: AMR R&#038;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP"},"content":{"rendered":"\n<p><strong>Speaker:&nbsp;<\/strong>Aleksandar Danilovski,&nbsp;<em>Chief Scientific Officer, Xellia Pharmaceuticals (Denmark)<\/em><\/p>\n\n\n\n<p><strong>Moderator:<\/strong>&nbsp;Michael Scholl,&nbsp;<em>Chief Executive Officer, Leukocare AG (Germany)<\/em><\/p>\n\n\n\n<p>Aleksandar\u2019s presentation will discuss:<\/p>\n\n\n\n<ul><li>Are CMC and formulation efforts treated as the foster child in the innovation and development armament?<\/li><li>Underestimating CMC and formulation aspects can potentially cause significant delays and project failures<\/li><li>Appropriate (what, how and when) CMC and formulation innovation and development strategies can improve overall probability of project success, can bring competitive advantages (including IP umbrella) and can reduce time to market<\/li><li>Do it right the first time!<\/li><\/ul>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p>The presentation will be followed by a Q&amp;A session.<\/p>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p>This live webinar including interactive Q&amp;A session will be broadcast on 29 April 2021 at 17:00-18:30 CEST. <\/p>\n\n\n\n<p>Find your time zone&nbsp;<a href=\"https:\/\/www.timeanddate.com\/worldclock\/converter.html?iso=20210429T150000&amp;p1=87\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a>.<\/p>\n\n\n\n<p>More about the event <a href=\"https:\/\/revive.gardp.org\/amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time\/\" target=\"_blank\" rel=\"noreferrer noopener\">on this link<\/a>.<\/p>\n\n\n\n<p>If you have questions or comments, please let us know:&nbsp;<a href=\"mailto:revive@gardp.org\">revive@gardp.org<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Speaker:&nbsp;Aleksandar Danilovski,&nbsp;Chief Scientific Officer, Xellia Pharmaceuticals (Denmark) Moderator:&nbsp;Michael Scholl,&nbsp;Chief Executive Officer, Leukocare AG (Germany) Aleksandar\u2019s presentation will discuss: Are CMC and formulation efforts treated as the foster child in the innovation and development armament? Underestimating CMC and formulation aspects can potentially cause significant delays and project failures Appropriate (what, how and when) CMC and formulation [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":10267,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[35],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Live webinar: AMR R&amp;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Live webinar: AMR R&amp;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-12T15:21:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-11T14:13:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"699\" \/>\n\t<meta property=\"og:image:height\" content=\"414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Live webinar: AMR R&#038;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP\",\"datePublished\":\"2021-04-12T15:21:59+00:00\",\"dateModified\":\"2021-10-11T14:13:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg\",\"articleSection\":[\"Ev\u00e8nements &amp; Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\",\"name\":\"Live webinar: AMR R&D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg\",\"datePublished\":\"2021-04-12T15:21:59+00:00\",\"dateModified\":\"2021-10-11T14:13:25+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg\",\"width\":699,\"height\":414,\"caption\":\"Cr\u00e9dit : Pixabay\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ev\u00e8nements &amp; Colloques\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Live webinar: AMR R&#038;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Live webinar: AMR R&D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/","og_locale":"fr_FR","og_type":"article","og_title":"Live webinar: AMR R&D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-04-12T15:21:59+00:00","article_modified_time":"2021-10-11T14:13:25+00:00","og_image":[{"width":699,"height":414,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Live webinar: AMR R&#038;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP","datePublished":"2021-04-12T15:21:59+00:00","dateModified":"2021-10-11T14:13:25+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/"},"wordCount":170,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg","articleSection":["Ev\u00e8nements &amp; Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/","name":"Live webinar: AMR R&D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg","datePublished":"2021-04-12T15:21:59+00:00","dateModified":"2021-10-11T14:13:25+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/04\/Reunion-online.jpg","width":699,"height":414,"caption":"Cr\u00e9dit : Pixabay"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/live-webinar-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time-29-april-2021-1700-1830-cesp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Ev\u00e8nements &amp; Colloques","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/evenements-colloques\/"},{"@type":"ListItem","position":4,"name":"Live webinar: AMR R&#038;D efforts in the CMC and formulation arena: Do it right the first time, 29 April 2021, 17:00-18:30 CESP"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-15 06:19:45","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/10251"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=10251"}],"version-history":[{"count":11,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/10251\/revisions"}],"predecessor-version":[{"id":17887,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/10251\/revisions\/17887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/10267"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=10251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=10251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=10251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}